Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXABEPILONE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where IXABEPILONE was used for Neoplasm malignant.

Most Reported Side Effects for IXABEPILONE

Side Effect Reports % Deaths Hosp.
Anaemia 55 15.0% 7 31
Death 49 13.3% 49 16
Neutrophil count decreased 48 13.0% 4 29
White blood cell count decreased 45 12.2% 6 29
Pseudocirrhosis 31 8.4% 14 4
Fatigue 30 8.2% 4 15
Vomiting 30 8.2% 9 19
Malignant neoplasm progression 26 7.1% 9 3
Nausea 25 6.8% 7 15
Platelet count decreased 25 6.8% 4 16
Portal hypertension 23 6.3% 7 1
Dyspnoea 22 6.0% 5 12
Disease progression 18 4.9% 3 4
Dehydration 17 4.6% 3 13
Hypokalaemia 17 4.6% 2 16

Other Indications for IXABEPILONE

Breast cancer metastatic (107) Breast cancer (52) Product used for unknown indication (37) Endometrial cancer (36) Ovarian cancer (12) Papillary serous endometrial carcinoma (12) Non-small cell lung cancer (10) Endometrial adenocarcinoma (8) Invasive ductal breast carcinoma (8) Breast cancer female (7)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

IXABEPILONE Full Profile All Neoplasm malignant Drugs IXABEPILONE Demographics IXABEPILONE Timeline